Adaptive BiotechnologiesADPT
那斯達克 · USD
24.20
-0.03
(-0.12%)
收盤 09/12 04:00 (UTC+8)
09/12 04:00 (UTC+8)
Adaptive BiotechnologiesADPT
24.20
-0.03
(-0.12%)
財務數據
損益表
- 0.42
- 0.43
- 0.46
- 0.47
- 0.52
- 0.59
- 0.94
- 0.72
- 0.71
- 0.72
- -8.54
- 3.15
- 7.51
- 2.21
- 10.50
- 12.27
- 59.60
- -23.72
- -1.13
- 0.96
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 71,553 | 70,874 | 71,681 | 93,973 | 58,879 | 52,443 | 47,459 | 46,435 | 43,190 | 41,873 |
營業成本 | 20,165 | 18,708 | 18,224 | 18,157 | 17,999 | 16,979 | 18,045 | 16,667 | 19,317 | 18,051 |
營業毛利 | 51,388 | 52,166 | 53,457 | 75,816 | 40,880 | 35,464 | 29,414 | 29,768 | 23,873 | 23,822 |
營業費用 | 67,158 | 71,372 | 66,230 | 65,526 | 65,916 | 65,068 | - | - | 71,191 | - |
研發費用 | 19,153 | 23,623 | 21,763 | 23,669 | 24,134 | 24,203 | 23,192 | 24,163 | 25,353 | 30,245 |
推銷及管理費用 | 47,582 | 47,330 | 44,038 | 41,429 | 41,359 | 40,446 | 39,631 | 37,809 | 38,209 | 41,916 |
非經常性項目費用 | - | - | - | - | - | - | - | - | 7,205 | - |
其他營業費用 | 423 | 419 | 429 | 428 | 423 | 419 | 428 | 428 | 424 | 423 |
營業利益 | -15,770 | -19,206 | -12,773 | 10,290 | -25,036 | -29,604 | -33,837 | -32,632 | -47,318 | -48,762 |
其他收入及費用 | -21,477 | 2,080 | 2,148 | 2,226 | 2,391 | 2,679 | 3,072 | 3,474 | 3,766 | 4,222 |
利息費用 | 2,694 | 2,889 | 2,954 | 2,971 | 2,948 | 2,905 | 2,952 | 2,939 | 2,696 | 2,993 |
稅前純益 | -39,941 | -20,015 | -13,579 | 9,545 | -25,593 | -29,830 | -33,717 | -32,097 | -46,248 | -47,533 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -39,788 | -20,033 | -13,579 | 9,546 | -25,614 | -29,852 | -33,692 | -32,071 | -46,222 | -47,507 |
基本每股稅後盈餘(元) | -0.25 | -0.13 | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 | -0.22 | -0.31 | -0.33 |
稀釋每股稅後盈餘(元) | -0.25 | -0.13 | -0.09 | 0.07 | -0.17 | -0.20 | -0.22 | -0.22 | -0.31 | -0.33 |
基本平均股數(千股) | 159855.00 | 155521.00 | 153127.00 | 152432.00 | 152082.00 | 149195.00 | 147677.00 | 147516.00 | 147414.00 | 145787.00 |
稀釋平均股數(千股) | 159855.00 | 155521.00 | 153127.00 | 163162.00 | 152082.00 | 149195.00 | 147677.00 | 147516.00 | 147414.00 | 145787.00 |
還原基本每股稅後盈餘(元) | -0.25 | -0.13 | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 | -0.22 | -0.31 | -0.33 |
還原稀釋每股稅後盈餘(元) | -0.25 | -0.13 | -0.09 | 0.07 | -0.17 | -0.20 | -0.22 | -0.22 | -0.31 | -0.33 |
還原基本平均股數(千股) | 159,855 | 155,521 | 153,127 | 152,432 | 152,082 | 149,195 | 147,677 | 147,516 | 147,414 | 145,787 |
還原稀釋平均股數(千股) | 159,855 | 155,521 | 153,127 | 163,162 | 152,082 | 149,195 | 147,677 | 147,516 | 147,414 | 145,787 |
EBITDA(千元) | -33,511 | -13,443 | -6,718 | 16,406 | -18,914 | -23,174 | -27,750 | -26,549 | -40,622 | -41,943 |